Home > Quotes > XPH

SPDR S&P Pharmaceuticals ETF Stock Quote & Summary Data

(ETF)
XPH 
$72.02
*  
0.21
  negative  
0.29%
Get XPH Alerts
*Delayed - data as of Jun. 19, 2013 


Community Rating:
View:    XPH After Hours
 
 

Symbol List Views

ETF Details

CHARTS

ETF NEWS

FUNDAMENTALS

Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.


Don't know the stock symbol? Use the symbol lookup tool.

Alphabetize the sort order of my symbols 
Symbol Lookup
Log in or Register
 Save stocks for next time
 | Sponsored

1 Year Target:
Today's High/Low:  / 
Share Volume:
90 Day Avg. Daily Volume This is the average share volume for the past 50 trading days, for NASDAQ stocks and 90 trading days for Non-NASDAQ stocks. This field allows you to compare today’s trading to the average daily volume. 40,079
Previous Close: $ 72.23
52 Week High /Low: $ 72.71 / $ 53.20
Market cap “Market Capitalization” is a measure of the estimated value of the common equity securities of the company or their equivalent. It does not include securities convertible into the common equity securities. “Market Capitalization” is derived from the last sale price for the displayed class of listed securities and the total number of shares outstanding for both listed and unlisted securities (as applicable). NASDAQ does not use this value to determine compliance with the listing requirements. $ 446,533,723
Annualized dividend $ 0.2689
Ex Dividend Date Mar. 15, 2013
Dividend Payment Date Mar. 25, 2013
Current Yield 0.37 %

 Intraday Chart

5d | 1m | 6m | 12m | More Charting



Description:The SPDR S&P Pharmaceuticals ETF seeks to replicate as closely as possible, before expenses, the performance of the S&P Pharmaceuticals Select Industry Index. The Index represents the pharmaceuticals sub-industry portion of the S&P Total Stock Market Index. The Index is one of nineteen (19) of the S&P Select Industry Indexes, each designed to measure the performance of a narrow sub-industry determined based on the Global Industry Classification Standards. Membership in the Select Industry Indexes is based on the GICS classification, as well as liquidity and market cap requirements. Companies in the Select Industry Indexes are classified based primarily on revenues; however, earnings and market perception are also considered. Under normal market conditions, the Fund generally invests substantially all, but at least 95%, of its total assets in the securities comprising the Index.

Underlying Index S&P Pharmaceuticals Select Industry Index
Management Fee 0.35
Asset Class Equity
Leverage 1


News Headlines for XPH

ETFs For The 'Third Scenario'
6/18/2013 3:00:00 AM - Seeking Alpha
These 3 Drug Stocks May Cure Summertime Blues
6/5/2013 2:06:00 PM - Seeking Alpha
Top 10 Healthcare Sector ETFs
5/30/2013 1:30:00 PM - Seeking Alpha
Warner Chilcott plc (WCRX) Ex-Dividend Date Scheduled for May 29, 2013
5/28/2013 9:00:04 AM - NASDAQ.com News
Perrigo Company (PRGO) Ex-Dividend Date Scheduled for May 29, 2013
5/28/2013 9:00:04 AM - NASDAQ.com News
Top Holdings
ABBV Abbvie Inc. Common Stock 4.78%
VVUS Vivus 4.75%
ENDP Endo Pharmaceuticals Holdings Inc. 4.72%
WPI Watson Pharmaceuticals 4.47%
ACT Actavis Inc. 4.68%
BMY Bristol-Myers Squibb Company 4.58%
SLXP Salix Pharmaceuticals 4.55%
VPHM Viropharma Inc. 4.4%
JAZZ Jazz Pharmaceuticals 4.51%
MRK Merck & Company 4.44%
JNJ Johnson & Johnson 4.37%
WCRX Warner Chilcott Plc 4.46%
AGN Allergan 4.35%
PFE Pfizer 4.33%
QCOR Questcor Pharmaceuticals 4.45%
LLY Eli Lilly And Company 4.31%
HSP Hospira Inc 4.28%
FRX Forest Laboratories 4.26%
ABT Abbott Laboratories 4.28%
PRGO Perrigo Company 4.29%